Tuesday, 15 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Drug
Frontier Biotech’s Albuvirtide Shows Promising HIV Treatment Results in Phase III Trial
March 25, 2025
Company
Organon’s China Head Shi Wang Departs to Lead Sanofi Greater China
March 25, 2025
Company
Drug
Antengene Receives Australian TGA Approval for ATG-018 Clinical Trial
March 25, 2025
Company
Deals
Helixon Secures RMB 500 Million in Series A Round to Advance AI-Driven Drug Development
March 25, 2025
Company
Drug
Jumbo Drug Bank’s JDB153 Enters Phase I Trial for Advanced Solid Tumors
March 25, 2025
Company
Drug
RemeGen’s Telitacicept Begins Global Phase III Trial for Severe SLE
March 25, 2025
Company
Deals
Suzhou Teligene Ltd Plans IPO on Shanghai STAR Market for Cancer Drug Development
March 25, 2025
Company
Drug
BrightGene Bio-Medical Technology Gains NMPA Approval for Oseltamivir Dry Suspension
March 25, 2025
Company
Drug
Rakuten Medical Taiwan Administers First Dose of ASP-1929 in Phase II Trial
March 25, 2025
Company
Drug
BeiGene’s Tislelizumab Accepted for Review in Gastric Cancer Treatment
March 25, 2025
Company
Drug
Zelgen’s Jakitinib Phase III Study Meets Primary Endpoint for Myelofibrosis
March 25, 2025
Company
Deals
Nanjing CRO Caremo Secures RMB 150 Million in Series A Round
March 25, 2025
1
2
…
1,187
1,188
1,189
1,190
1,191
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?